New options for anticoagulation in congenital and pediatric acquired heart disease

INIS

• pediatrics 100%
• heart disease 50%
• patients 33%
• heparin 33%
• congenital diseases 33%
• anticoagulants 33%
• thrombin 33%
• drugs 16%
• clinical trials 16%
• interactions 16%
• children 16%
• populations 16%
• reviews 16%
• administration 16%
• solutions 16%
• molecular weight 16%
• vitamin k 16%

Medicine and Dentistry

• Pediatrics 83%
• Antithrombotic 33%
• Direct Thrombin Inhibitor 33%
• Blood Clotting Factor 10a Inhibitor 33%
• Pharmacokinetics 16%
• Patient Population 16%
• Pediatrics Patient 16%
• Heparin 16%
• Anticoagulation 16%
• Low Molecular Weight Heparin 16%
• Chemotherapeutic Agent 16%
• Drug 16%
• Vitamin K Antagonist 16%
• Patient 16%
• Child 16%
• Medication 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Heart Disease 50%
• Anticoagulant Agent 33%
• Thrombin Inhibitor 33%
• Blood Clotting Factor 10a Inhibitor 33%
• Clinical Trial 33%
• Pharmacokinetics 16%
• Heparin 16%
• Low Molecular Weight Heparin 16%
• Antivitamin K 16%
• Drug 16%